Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 19 de 19
Clin J Oncol Nurs ; 25(5): 1-2, 2021 10 01.
Article in English | MEDLINE | ID: covidwho-1435276


The Oncology Nursing Society (ONS) has made marked contributions to the art and science of nursing, including establishment of resources and a community for oncology nurses across the United States. ONS's core values have evolved to innovation, excellence, advocacy, and inclusivity (ONS, 2021). While we know that these core values are, in virtue, admirable, there is a stark need to address another value-equity.

Oncology Nursing , Societies, Nursing , Delivery of Health Care , Humans , Societies , United States
Science ; 373(6559): 1099, 2021 09 03.
Article in English | MEDLINE | ID: covidwho-1434870


[Figure: see text].

JAMA Netw Open ; 4(8): e2119621, 2021 08 02.
Article in English | MEDLINE | ID: covidwho-1359743


Importance: In 2020 and early 2021, the National Football League (NFL) and National Collegiate Athletic Association (NCAA) opted to host football games in stadiums across the country. The in-person attendance of games varied with time and from county to county. There is currently no evidence on whether limited in-person attendance of games is associated with COVID-19 case numbers on a county-level. Objective: To assess whether NFL and NCAA football games with limited in-person attendance were associated with increased COVID-19 cases in the counties they were held compared with a matched set of counties. Design, Setting, and Participants: In this time-series cross-sectional study, every county hosting NFL or NCAA games with in-person attendance (treated group) in 2020 and 2021 was matched with a county that that did not host a game on the corresponding day but had an identical game history for up to 14 days prior (control group). A standard matching method was used to further refine this matched set so that the treated and matched control counties had similar population size, nonpharmaceutical interventions in place, and COVID-19 trends. The association of hosting games with in-person attendance with COVID-19 cases was assessed using a difference-in-difference estimator. Data were analyzed from August 29 to December 28, 2020. Exposures: Hosting NFL or NCAA games. Main Outcomes and Measures: The main outcome was estimation of new COVID-19 cases per 100 000 residents at the county level reported up to 14 days after a game among counties with NFL and NCAA games with in-person attendance. Results: A total of 528 games with in-person attendance (101 NFL games [19.1%]; 427 NCAA games [80.9%]) were included. The matching algorithm returned 361 matching sets of counties. The median (interquartile range [IQR]) number of attendance for NFL games was 9949 (6000 to 13 797) people. The median number of attendance for NCAA games was not available, and attendance was recorded as a binary variable. The median (IQR) daily new COVID-19 cases in treatment group counties hosting games was 26.14 (10.77-50.25) cases per 100 000 residents on game day. The median (IQR) daily new COVID-19 cases in control group counties where no games were played was 24.11 (9.64-48.55) cases per 100 000 residents on game day. The treatment effect size ranged from -5.17 to 4.72, with a mean (SD) of 1.21 (2.67) cases per 100 000 residents, within the 14-day period in all counties hosting the games, and the daily treatment effect trend remained relatively steady during this period. Conclusions and Relevance: This cross-sectional study did not find a consistent increase in the daily COVID-19 cases per 100 000 residents in counties where NFL and NCAA games were held with limited in-person attendance. These findings suggest that NFL and NCAA football games hosted with limited in-person attendance were not associated with substantial risk for increased local COVID-19 cases.

COVID-19/epidemiology , Communicable Disease Control/statistics & numerical data , Population Health/statistics & numerical data , Sentinel Surveillance , Sports and Recreational Facilities/statistics & numerical data , COVID-19/prevention & control , COVID-19/transmission , Communicable Disease Control/methods , Cross-Sectional Studies , Football , Humans , Organizations, Nonprofit , SARS-CoV-2 , Societies , United States/epidemiology , Universities
J Histotechnol ; 43(4): 162, 2020 12.
Article in English | MEDLINE | ID: covidwho-1276026
Rev. colomb. anestesiol ; 49(3): e100, July-Sept. 2021.
Article in English | LILACS (Americas) | ID: covidwho-1262655


While pondering about a way to convey a message of hope, kindness and solidarity to my anesthesiology colleagues and to all the healthcare professionals and workers in Colombia and around the world, who are in the frontlines of the COVID-19 pandemic, I realized - once again- the severe impact it has had on our mental health and our lives. In the history of our generation and probably since 1918, mankind had not experienced the deleterious effect of a pandemic of such magnitude on our lives. A disrupting event of such magnitude invites us to reflect daily. So, I remembered that we, Colombian anesthesiologists, have a fantastic leader who sets an example for many of us, and who is renowned worldwide. A global leader in innovation and the creation of the future: Professor Alejandro Jadad. He used to speak often about pandemics, but pandemics of health and joy.

Mientras reflexionaba sobre una manera de transmitir un mensaje de esperanza, amabilidad y solidaridad a mis colegas de anestesiología y a todos los profesionales y trabajadores de la salud en Colombia y en todo el mundo, que se encuentran en la primera línea de la pandemia de COVID-19, me di cuenta: una vez de nuevo, el impacto severo que ha tenido en nuestra salud mental y nuestras vidas. En la historia de nuestra generación y probablemente desde 1918, la humanidad no había experimentado el efecto deletéreo de una pandemia de tal magnitud en nuestras vidas. Un acontecimiento perturbador de tal magnitud nos invita a reflexionar a diario. Entonces, recordé que nosotros, los anestesiólogos colombianos, tenemos un líder fantástico que es un ejemplo para muchos de nosotros y que es reconocido mundialmente. Líder mundial en innovación y creación de futuro: el profesor Alejandro Jadad. Solía ​​hablar a menudo de pandemias, pero de pandemias de salud y alegría.

Humans , Health Personnel , Delivery of Health Care , Pandemics , Anesthesiology , Occupational Groups , Societies , Health , Mental Health , Richter Scale , Anesthesiologists , History
Orphanet J Rare Dis ; 16(1): 119, 2021 03 05.
Article in English | MEDLINE | ID: covidwho-1119432


BACKGROUND: This study assesses the areas and extent of impact of the Coronavirus Disease of 2019 (COVID-19) pandemic on rare disease (RD) organisations in the Asia Pacific region. There is no existing literature that focuses on such impact on RD organisations in any jurisdictions, nor RD populations across multiple jurisdictions in the Asia Pacific region. A cross-sectional survey was distributed to RD organisations between April and May 2020. Quantitative and qualitative data on the impact of COVID-19 on RD organisations and patients were collected from the organisation representative's perspective. Qualitative data was analysed using thematic analysis. A follow-up focus group meeting was conducted in August 2020 to validate the survey findings and to discuss specific needs, support and recommendations for sustainable healthcare systems during the pandemic. RESULTS: A total of 80 RD organisations from Australia, Hong Kong Special Administrative Region of China, India, Japan, mainland China, Malaysia, New Zealand, the Philippines, Singapore and Taiwan participated in the study. Of all, 89% were concerned about the impact of pandemic on their organisations. Results indicate that 63% of the organisations functioned at a reduced capacity and 42% stated a decrease in funding as their biggest challenge. Overall, 95% believed their patients were impacted, particularly in healthcare access, social lives, physical health, psychological health and financial impact. Specifically, 43% identified the reduced healthcare access as their top impact, followed by 26% about the impact on daily living and social life. Focus group meeting discussed differential impact across jurisdictions and point towards telemedicine and digitalisation as potential solutions. CONCLUSIONS: This serves as the first study to assess the impact of COVID-19 on RD patients and organisations across multiple jurisdictions in the Asia Pacific region, identifying major themes on the impact on both RD patients and organisations. By including 80 organisations from ten jurisdictions, our study presents the most comprehensive assessment of the pandemic's impact to date. It highlights the need for mental health support and sheds light on moving towards telemedicine and digitalisation of organisation operation, which constitutes a sustainable model in times of pandemics and beyond.

COVID-19/complications , COVID-19/epidemiology , Pandemics , Rare Diseases/complications , Societies/organization & administration , Asia/epidemiology , COVID-19/virology , Cross-Sectional Studies , Humans , Oceania/epidemiology , SARS-CoV-2/isolation & purification
J Clin Microbiol ; 59(5)2021 04 20.
Article in English | MEDLINE | ID: covidwho-1039851
Rev. colomb. anestesiol ; 48(4): e100, Oct.-Dec. 2020.
Article in English | LILACS (Americas) | ID: covidwho-914696


In December 2019, an outbreak of a respiratory desease caused by a new coronavirus strain was detected in Wuhan, China. The disease spread rapidly around the world and was recognized as a pandemic by the World Health Organization in March 2020. From the very beginning of the pandemic, society was faced with a scenario fraught with uncertainty: a new disease with severe effects on some patients and no specific treatment. The medical community reacted promptly and undertook the quest for treatment options, some based on prior experiences with diseases caused by other coronavirus strains or related viruses, and other approaches based on potential pathophysiological mechanisms promising at the time but without any supporting scientific evidence.

En diciembre de 2019, se detectó en Wuhan (China) un brote de una enfermedad respiratoria causada por una nueva cepa de coronavirus. La enfermedad se extendió rápidamente por todo el mundo y fue reconocida como pandemia por la Organización Mundial de la Salud en marzo de 2020. Desde el principio de la pandemia, la sociedad se enfrentó a un escenario cargado de incertidumbre: una nueva enfermedad con graves efectos en algunos pacientes y sin tratamiento específico. La comunidad médica reaccionó rápidamente y emprendió la búsqueda de opciones de tratamiento, algunas basadas en experiencias previas con enfermedades causadas por otras cepas de coronavirus o virus relacionados, y otras aproximaciones basadas en posibles mecanismos fisiopatológicos prometedores en ese momento pero sin ninguna evidencia científica que los respaldara.

Humans , Respiratory Tract Diseases , Decision Making , SARS-CoV-2 , Societies , Pharmaceutical Preparations/administration & dosage , Pandemics , COVID-19
Vet Rec ; 187(1): 34, 2020 07.
Article in English | MEDLINE | ID: covidwho-732172

Societies , Surgeons , Animals , Humans
PLoS One ; 15(8): e0237304, 2020.
Article in English | MEDLINE | ID: covidwho-709347


The COVID-19 pandemic has already had a shocking impact on the lives of everybody on the planet. Here, we present a modification of the classical SI model, the Fractal Kinetics SI model which is in excellent agreement with the disease outbreak data available from the World Health Organization. The fractal kinetic approach that we propose here originates from chemical kinetics and has successfully been used in the past to describe reaction dynamics when imperfect mixing and segregation of the reactants is important and affects the dynamics of the reaction. The model introduces a novel epidemiological parameter, the "fractal" exponent h which is introduced in order to account for the self-organization of the societies against the pandemic through social distancing, lockdowns and flight restrictions.

Betacoronavirus , Coronavirus Infections/epidemiology , Fractals , Pneumonia, Viral/epidemiology , COVID-19 , Coronavirus Infections/virology , Humans , Kinetics , Pandemics , Pneumonia, Viral/virology , Principal Component Analysis , Quarantine/methods , SARS-CoV-2 , Societies
Pulmonology ; 26(6): 386-397, 2020.
Article in English | MEDLINE | ID: covidwho-694065


Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel SARS-CoV-2 pathogen. Its capacity for human-to-human transmission through respiratory droplets, coupled with a high-level of population mobility, has resulted in a rapid dissemination worldwide. Healthcare workers have been particularly exposed to the risk of infection and represent a significant proportion of COVID-19 cases in the worst affected regions of Europe. Like other open airway procedures or aerosol-generating procedures, bronchoscopy poses a significant risk of spreading contaminated droplets, and medical workers must adapt the procedures to ensure safety of both patients and staff. Several recommendation documents were published at the beginning of the pandemic, but as the situation evolves, our thoughts should not only focus on the present, but should also reflect on how we are going to deal with the presence of the virus in the community until there is a vaccine or specific treatment available. It is in this sense that this document aims to guide interventional pulmonology throughout this period, providing a set of recommendations on how to perform bronchoscopy or pleural procedures safely and efficiently.

Betacoronavirus , Bronchoscopy/methods , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Pulmonary Medicine/methods , Aerosols , COVID-19 , Consensus , Disease Outbreaks , Humans , Portugal , SARS-CoV-2 , Societies
Rofo ; 192(7): 633-640, 2020 07.
Article in English, German | MEDLINE | ID: covidwho-401514


This information provided by the Thoracic Imaging Section of the German Radiological Society is intended to give physicians recommendations on the use of thoracic imaging procedures in the context of the current COVID-19 pandemic. It represents the consensus of the authors based on the previous scientific knowledge and is intended to provide guidance for unified, structured CT reporting if COVID-19 pneumonia is suspected. The recommendations presented correspond to state of knowledge at the time of print and will be updated according to the results of ongoing and future scientific studies. KEY POINTS:: · COVID-19. · chest imaging. · German Radiological Society. CITATION FORMAT: · Vogel-Claussen J, Ley-Zaporozhan J, Agarwal P et al. Recommendations of the Thoracic Imaging Section of the German Radiological Society for clinical application of chest imaging and structured CT reporting in the COVID-19 pandemic. Fortschr Röntgenstr 2020; DOI: 10.1055/a-1174-8378.

Coronavirus Infections/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Radiography, Thoracic/methods , Tomography, X-Ray Computed , COVID-19 , Germany , Humans , Pandemics , Radiography, Thoracic/standards , Radiology/standards , Societies